Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Krystal Biotech stock

Learn how to easily invest in Krystal Biotech stock.

Krystal Biotech is a biotechnology business based in the US. Krystal Biotech shares (KRYS) are listed on the NASDAQ and all prices are listed in US Dollars. Krystal Biotech employs 119 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Krystal Biotech stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – KRYS. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Krystal Biotech stock price (NASDAQ: KRYS)

Use our graph to track the performance of KRYS stocks over time.

Krystal Biotech shares at a glance

Information last updated 2023-01-25.
Latest market close$84.22
52-week range$47.67 - $85.65
50-day moving average $77.56
200-day moving average $70.33
Wall St. target price$107.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-4.48

Buy Krystal Biotech stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Krystal Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Krystal Biotech price performance over time

Historical closes compared with the close of $84.22 from 2023-01-27

1 week (2023-01-24) 1.18%
1 month (2022-12-30) 6.31%
3 months (2022-10-31) 10.09%
6 months (2022-07-29) 16.04%
1 year (2022-01-28) 56.66%
2 years (2021-01-29) 20.83%
3 years (2020-01-31) 61.16%
5 years (2018-01-30) 738.84%

Krystal Biotech financials

Gross profit TTM $0
Return on assets TTM -13.4%
Return on equity TTM -27.34%
Profit margin 0%
Book value $21.03
Market capitalisation $2.2 billion

TTM: trailing 12 months

Krystal Biotech share dividends

We're not expecting Krystal Biotech to pay a dividend over the next 12 months.

Krystal Biotech share price volatility

Over the last 12 months, Krystal Biotech's shares have ranged in value from as little as $47.67 up to $85.65. A popular way to gauge a stock's volatility is its "beta".

KRYS.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Krystal Biotech's is 0.8762. This would suggest that Krystal Biotech's shares are less volatile than average (for this exchange).

Krystal Biotech overview

Krystal Biotech, Inc. , a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Frequently asked questions

What percentage of Krystal Biotech is owned by insiders or institutions?
Currently 16.424% of Krystal Biotech shares are held by insiders and 82.325% by institutions.
How many people work for Krystal Biotech?
Latest data suggests 119 work at Krystal Biotech.
When does the fiscal year end for Krystal Biotech?
Krystal Biotech's fiscal year ends in December.
Where is Krystal Biotech based?
Krystal Biotech's address is: 2100 Wharton Street, Pittsburgh, PA, United States, 15203
What is Krystal Biotech's ISIN number?
Krystal Biotech's international securities identification number is: US5011471027
What is Krystal Biotech's CUSIP number?
Krystal Biotech's Committee on Uniform Securities Identification Procedures number is: 501147102

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site